Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity

Fig. 3

Kaplan–Meier Survival Curves—Progression Free Survival, A Overall survival rate as a percent plotted against time in months of all patients, combined. B Overall survival rate as a percent plotted against time in months of three categories of patients. The patient categories are primary, recurrent, or metastatic

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us